https://mepa8.com/medicine/2026/10/21/hibsago-bepirovirsen-fda-approval-for-chronic-hepatitis-b/ Mepa8en 2026-10-21T13:27:14-07:00 FDA approves Hibsago, first antisense drug for chronic hepatitis B, with boxed warning Hibsago, bepirovirsen, FDA approval hepatitis B, chronic hepatitis B treatment, antisense oligonucleotide hepatitis B, GSK hepatitis B drug, Hibsago boxed warning, Elecsys HBsAg II quant II RxDx https://mepa8.com/assets/img/hibsago-bepirovirsen-fda-approval-for-chronic-hepatitis-b-1600.jpg https://mepa8.com/ems/2026/10/21/bystander-cpr-rose-in-french-dispatcher-and-app-trial/ Mepa8en 2026-10-21T13:12:47-07:00 Dispatcher and volunteer-app package raised bystander CPR in French trial but not outcomes bystander CPR trial France, dispatcher-assisted CPR, telephone CPR stepped-wedge trial, out-of-hospital cardiac arrest bystander CPR, volunteer responder app cardiac arrest, Lancet Public Health bystander CPR, Debaty bystander CPR trial, NCT03633370 https://mepa8.com/assets/img/bystander-cpr-rose-in-french-dispatcher-and-app-trial-1600.jpg https://mepa8.com/recalls/2026/10/21/safeguard-battle-bandage-ifak-kit-recall-fda-class-ii/ Mepa8en 2026-10-21T12:57:57-07:00 FDA posts Class II recall of Safeguard Battle Bandage and IFAK trauma kits, 46,881 units Safeguard Battle Bandage recall, Safeguard IFAK recall, Battle Bandage 32-700 recall, FDA Class II recall IFAK, Z-0081-2027, Patrol IFAK bag recall, compression bandage recall 2026, Safeguard US Operating LLC recall https://mepa8.com/assets/img/safeguard-battle-bandage-ifak-kit-recall-fda-class-ii-1600.jpg